Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly

Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly ID - 450033 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450033/all/Melphalan_and_prednisolone_plus_thalidomide_compared_to_other_treatments_for_multiple_myeloma_in_the_elderly PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -